ARVEE vs GRAUWEIL: Stock Comparison

Arvee Laboratories (India) Limited vs Grauer & Weil (India) Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Grauer & Weil (India) Ltd is the larger company by market capitalisation. Arvee Laboratories (India) Limited shows faster revenue growth, while Grauer & Weil (India) Ltd shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Arvee Laboratories (India) Limited and Grauer & Weil (India) Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ARVEE is more favourable on 4 of 13 scored metrics and GRAUWEIL on 9These counts are context-free and are not an overall rating.

Key Differences

Market Cap
GRAUWEIL is the larger company
₹3,346 Cr vs ₹171 Cr
P/E Ratio
GRAUWEIL has a lower P/E
20.49x vs 69.87x
P/B Ratio
GRAUWEIL has a lower P/B
3.11x vs 5.22x
EPS
GRAUWEIL has higher earnings per share
₹3.62 vs ₹1.88
Dividend Yield
GRAUWEIL has a higher dividend yield
0.62% vs 0%
Revenue Growth (TTM YoY)
ARVEE has faster revenue growth
67.5% vs 0%
EPS Growth (TTM YoY)
ARVEE has faster EPS growth
684.4% vs 0%
Qtr Sales Growth
ARVEE has stronger quarterly sales growth
67.4% vs 4.49%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricARVEEGRAUWEIL
SectorChemicals
IndustrySpecialty Chemicals

Price

MetricARVEEGRAUWEIL
Live Price₹153.66₹73.97
Day Change-2.99%0.24%
Volume4621.12 L
52-Week High₹290.78₹87.4
52-Week Low₹129.11₹62.09
Distance from 52W High-47.16%-15.37%

Valuation

MetricARVEEGRAUWEIL
Market Cap₹171 Cr₹3,346 Cr
P/E Ratio69.87x20.49x
P/B Ratio5.22x3.11x
EPS₹1.88₹3.62
Book Value₹30.53₹23.9
Dividend Yield0%0.62%

Growth

MetricARVEEGRAUWEIL
Revenue Growth (TTM YoY)67.5%0%
EPS Growth (TTM YoY)684.4%0%
Qtr Sales Growth67.4%4.49%
Qtr Profit Growth643%92.4%

Profitability & Leverage

MetricARVEEGRAUWEIL
ROE7.78%16.2%
ROCE7.92%21.4%
Net Margin7.65%13.78%
Operating Margin10.1%16.2%
Debt to Equity0.03x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricARVEEGRAUWEIL
Promoter Holding73.5%69.03%
FII Holding0%0.42% 0.17 pp
DII Holding0%0.06% 0.04 pp
Public Holding26.5%30.49% 0.14 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Arvee Laboratories (India) Limited and Grauer & Weil (India) Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.